{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=ANCA-associated+Vasculitis", "query": { "condition": "ANCA-associated Vasculitis" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 90, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=ANCA-associated+Vasculitis&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-22T19:00:20.281Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02257866", "title": "Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Takayasu's Arteritis", "Giant Cell Arteritis", "Polyarteritis Nodosa", "Relapsing Polychondritis", "ANCA-Associated Vasculitis" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "3 Years", "maximum_age": null, "sex": "ALL", "summary": "3 Years and older" }, "enrollment_count": 4000, "start_date": "2014-09-29", "completion_date": "2050-01-01", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-09-22T19:00:20.281Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02257866" }, { "nct_id": "NCT03712345", "title": "Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Granulomatosis With Polyangiitis (GPA)", "Microscopic Polyangiitis (MPA)" ], "interventions": [ { "name": "IFX-1 low dose", "type": "DRUG" }, { "name": "IFX-1 high dose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "InflaRx GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2018-10-15", "completion_date": "2021-05-03", "has_results": true, "last_update_posted_date": "2022-05-26", "last_synced_at": "2026-09-22T19:00:20.281Z", "location_count": 33, "location_summary": "Scottsdale, Arizona • Loma Linda, California • Doral, Florida + 30 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Loma Linda", "state": "California" }, { "city": "Doral", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03712345" }, { "nct_id": "NCT00405860", "title": "CellCept in p-ANCA Vasculitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "MPO-ANCA Vasculitis", "Microscopic Polyangiitis" ], "interventions": [ { "name": "CellCept (mycophenolate mofetil)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2002-12", "completion_date": "2008-07", "has_results": false, "last_update_posted_date": "2011-03-23", "last_synced_at": "2026-09-22T19:00:20.281Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00405860" }, { "nct_id": "NCT07176546", "title": "TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Granulomatosis With Polyangiitis", "Wegener's", "GPA" ], "interventions": [ { "name": "Avacopan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Robert Spiera, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2026-05-22", "completion_date": "2030-10", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-09-22T19:00:20.281Z", "location_count": 2, "location_summary": "Edison, New Jersey • New York, New York", "locations": [ { "city": "Edison", "state": "New Jersey" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07176546" }, { "nct_id": "NCT00001759", "title": "Assessment of Lung Inflammation in Patients With Atopic Asthma Using Positron Emission Tomography", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Asthma", "Hypersensitivity", "Lung Diseases", "Wegener's Granulomatosis" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 95, "start_date": "1997-12", "completion_date": "2001-01", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-09-22T19:00:20.281Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001759" }, { "nct_id": "NCT03919435", "title": "TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Granulomatosis With Polyangiitis", "Wegener Granulomatosis" ], "interventions": [ { "name": "Trimethoprim Sulfamethoxazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2019-03-27", "completion_date": "2027-12-30", "has_results": false, "last_update_posted_date": "2025-11-19", "last_synced_at": "2026-09-22T19:00:20.281Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03919435" }, { "nct_id": "NCT03004326", "title": "Clinical Transcriptomics in Systemic Vasculitis (CUTIS)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cryoglobulinemic Vasculitis (CV)", "Drug-induced Vasculitis", "Eosinophilic Granulomatosis With Polyangiitis (EGPA)", "IgA Vasculitis", "Isolated Cutaneous Vasculitis", "Granulomatosis With Polyangiitis (GPA)", "Microscopic Polyangiitis (MPA)", "Polyarteritis Nodosa (PAN)", "Urticarial Vasculitis", "Vasculitis" ], "interventions": [], "intervention_types": [], "sponsor": "Peter Merkel", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 50, "start_date": "2017-01", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-09-22T19:00:20.281Z", "location_count": 8, "location_summary": "Los Angeles, California • Boston, Massachusetts • Rochester, Minnesota + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03004326" }, { "nct_id": "NCT06004934", "title": "A Study to Evaluate the Pharmacokinetics of Avacopan (CCX168) in Participants With Mild or Moderate Hepatic Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatic Impairment" ], "interventions": [ { "name": "Avacopan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 24, "start_date": "2018-04-17", "completion_date": "2018-09-18", "has_results": false, "last_update_posted_date": "2023-08-22", "last_synced_at": "2026-09-22T19:00:20.281Z", "location_count": 1, "location_summary": "Hialeah, Florida", "locations": [ { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06004934" }, { "nct_id": "NCT02476292", "title": "Impact of Vasculitis on Employment and Income", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Vasculitis", "Systemic Vasculitis", "Behcet's Disease", "CNS Vasculitis", "Cryoglobulinemic Vasculitis", "Eosinophilic Granulomatosis", "Temporal Arteritis", "Wegener Granulomatosis", "Henoch-Schoenlein Purpura", "Microscopic Polyangiitis", "Polyarteritis Nodosa (PAN)", "Takayasu's Arteritis", "Urticarial Vasculitis" ], "interventions": [ { "name": "online questionnaire", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 426, "start_date": "2015-06", "completion_date": "2016-01", "has_results": false, "last_update_posted_date": "2016-01-28", "last_synced_at": "2026-09-22T19:00:20.281Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02476292" }, { "nct_id": "NCT06004947", "title": "A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis" ], "interventions": [ { "name": "CCX168", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" }, { "name": "Itraconazole", "type": "DRUG" }, { "name": "Rifampicin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 32, "start_date": "2016-01-14", "completion_date": "2016-06-10", "has_results": false, "last_update_posted_date": "2023-08-22", "last_synced_at": "2026-09-22T19:00:20.281Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06004947" } ] }